PatientsVille.com Logo

CHRONIC OBSTRUCTIVE PULMONARY DISEASE and Hydroxyzine

PatientsVille

CHRONIC OBSTRUCTIVE PULMONARY DISEASE Symptoms and Causes

COPD (chronic obstructive pulmonary disease) makes it hard for you to breathe. The two main types are chronic bronchitis and emphysema. The main cause of COPD is long-term exposure to substances that irritate and damage the lungs. This is usually cigarette smoke. Air pollution, chemical fumes, or dust can also cause it.

At first, COPD may cause no symptoms or only mild symptoms. As the disease gets worse, symptoms usually become more severe. They include

  • A cough that produces a lot of mucus
  • Shortness of breath, especially with physical activity
  • Wheezing
  • Chest tightness

Doctors use lung function tests, imaging tests, and blood tests to diagnose COPD. There is no cure. Treatments may relieve symptoms. They include medicines, oxygen therapy, surgery, or a lung transplant. Quitting smoking is the most important step you can take to treat COPD.

NIH: National Heart, Lung, and Blood Institute

Check out the latest treatments for CHRONIC OBSTRUCTIVE PULMONARY DISEASE

CHRONIC OBSTRUCTIVE PULMONARY DISEASE treatment research studies

Hydroxyzine clinical trials, surveys and public health registries


Find Drug Side Effect reports



Hydroxyzine Side Effects

Completed Suicide (135)
Poisoning (62)
Cardiac Arrest (62)
Respiratory Arrest (57)
Death (29)
Toxicity To Various Agents (21)
Overdose (20)
Cardio-respiratory Arrest (18)
Nausea (17)
Anxiety (17)
Dizziness (17)
Somnolence (16)
Headache (16)
Exposure Via Ingestion (15)
Pyrexia (15)
Suicide Attempt (14)
Fall (14)
Pain In Extremity (13)
Pain (13)
Dyspnoea (13)
Condition Aggravated (12)
Confusional State (12)
Tremor (12)
Pruritus (12)
Abdominal Pain (11)
Depression (11)
Vomiting (11)
Fatigue (11)
Convulsion (10)
Asthenia (10)
Diarrhoea (10)
Feeling Abnormal (10)
Tachycardia (10)
Oedema Peripheral (10)
Injection Site Pain (10)
Balance Disorder (9)
Insomnia (9)
Dermatitis Exfoliative (9)
Syncope (9)
Torsade De Pointes (9)
Paraesthesia (8)
Grand Mal Convulsion (8)
Hypotension (8)
Septic Shock (8)
Urticaria (8)
Malaise (7)
Injury (7)
Pleural Effusion (7)
Psoriasis (7)
Myocardial Infarction (7)

➢ More


Common Meds

Abilify (10132)
Adderall (1304)
Amlodipine (6664)
Amoxicillin (4387)
Benadryl (1568)
Celebrex (12876 )
Celexa (1342)
Cialis (2975)
Cipro (8580)
Citalopram (7792)
Crestor (18839)
Cymbalta (14373)
Doxycycline (1757)
Effexor (7289)
Flexeril (435)
Flomax (2177)
Fluoxetine (4261)
Gabapentin (4593)
Hydrocodone (2469)
Ibuprofen (8222)
Lantus (10968)
Lexapro (3499)
Lipitor (17769)
Lisinopril (8919)
Lyrica (27148)
Medrol (650)
Mirena (41254)
Mobic (957)
Morphine (5356)
Naproxen (538)
Neurontin (6501)
Oxycodone (4438)
Pradaxa (13372)
Prednisone (5926)
Prilosec (2631)
Prozac (1954)
Seroquel (27216)
Simvastatin (8348)
Synthroid (4452)
Tamiflu (5585)
Topamax (3748)
Tramadol (5054)
Trazodone (1458)
Viagra (5394)
Vicodin (1153)
Wellbutrin (6324)
Xanax (2847)
Zocor (5718)
Zoloft(6792)
Zyrtec(1669)

Recent Reviews

Can you take this medicine with glaucoma

Hydroxozine hcl is working great to calm my nerves. But, I'm trying to decide if the joint pain is worth it. I believe I have a tic disorder, not anxiety. I've only had one dr visit and they are treating anxiety. But if I don't take roughly, 1200mg o

A flu epidemic at a boarding school would be a concern for the Centers for Disease Control true or false?

Why do doctors keep the availabilty of the test for DPD deficiency a secret??? My sister is a doctor, infectious disease, at St Francis in Charleston, SC. Our father was treated by an oncologist well known to my sister, a 'colleague' you might s

I am having cramps, muscle pain, memory loss, I have been on Revlmid for about 1 year. Does anybody else my age have this disease, I am only 46 yr woman.

<b>Describe Your Ezetrol Experience Here:</b>Sleeplessness severe pain in muscles and joints nausea and abdominal pain headaches and pain behind eyes chronic fatigue and flat mood

<b><span style=' padding: 0px; margin: 0px;'>Hi Can any1 tell me why this medicine (Betaserc) people use and if the disease is dangerous....plz tell me on urgent basis...any1 thnx</b>

My father is suffrering from idiotypic Pulmonary Fibrosis. In medication he is taking Prednisone,Perfenodone and azathropine. he is now geeting bleeding from his nose.Can anybody inform me that this is just a side effect of any d

<strong>I am on Cipralex now for about 2-3 months -10mg in the morning for depression, and now am experiencing chronic muscle weakness, chronic pain in both wrists and left hip, chronic fatigue, nausea, constant dizziness, tremors/shaky, restle

<strong>I have very high blood pressure, was put on this drug approximately 5 weeks ago. I was on Coozar previous to this. I also take paracetamol x 1 bd, ceres x 1, venlafaxine x 1, omeprazole x 1, aspirin x 1, have Charcot Marie Tooth Disease

48 yr old male, ~190lbs, started ~4 weeks ago on 25 mg nortriptyline / 1x per day for chronic headaches / migraines. Very tired first few days to the point where I was sleeping 12+ hrs / day. Evened out over time. Now I

55 yo dx with osearthritis and degenative disc disease, prescribed Mobic 15 mg once a day on medication for past year with no problem.For the past 6weeks had gradual onset of facial and extremity edema , esophageal spasm and expir

CHRONIC OBSTRUCTIVE PULMONARY DISEASE Clinical Trials and Studies

Treatments might be new drugs or new combinations of drugs, new surgical procedures or devices, or new ways to use existing treatments. The goal of clinical trials is to determine if a new test or treatment works and is safe. Clinical trials can also look at other aspects of care, such as improving the quality of life for people with chronic illnesses. People participate in clinical trials for a variety of reasons. Healthy volunteers say they participate to help others and to contribute to moving science forward. Participants with an illness or disease also participate to help others, but also to possibly receive the newest treatment and to have the additional care and attention from the clinical trial staff.
Rank Status Study
1 Unknown  Comparing the Efficacy of Pregabalin and Hydroxyzine on the Anxiety Score
Condition: Feeling Anxious
Interventions: Drug: Hydroxyzine;   Drug: Pregabalin;   Drug: Lactose
Outcome Measures: Efficacy treatment;   Efficacy of pregabaldin
2 Recruiting Pain and Anxiety Management of Traumatic Emergency in a Pre-hospital Setting
Condition: Pain
Interventions: Drug: Atarax (Hydroxyzine);   Drug: Placebo
Outcome Measures: Percentage of patients with pain relief (with a NRS score of 3/10 or lower);   pain score comparisons;   pain and anxiety comparisons;   comparison of adverse events;   patient and investigator satisfaction with analgesia;   assessment of post traumatic anxiety, stress and other related disorders
3 Recruiting Does Preventive Analgesia Improve the Outcome of Demerol-Vistaril Procedural Sedations in Pediatric Dentistry
Condition: Pain
Interventions: Drug: oral placebo;   Drug: Oral Analgesics
Outcome Measures: Improved sedation effectiveness based on numerical value for effectiveness as noted in description;   Difference in heart rate as measured by numerical delta value
4 Recruiting Interaction Between Drug and Placebo Effect:Randomized Placebo Controlled Trials May Not be Accurate in Determining Drug Effect Size
Conditions: Placebo Effect;   Placebo Drug Interaction
Interventions: Drug: Hydroxizine;   Other: Placebo;   Drug: Hydroxyzine/placebo
Outcome Measures: Area-under-the-curve for drowsiness;   Area-under-the-curve for dryness of the mouth;   Mean percent of time of reporting drowsiness on a dichotomous scale.;   Mean percent of time of reporting dryness of mouth
5 Unknown  Enteral Versus Intravenous Sedation in Critically Ill High-risk ICU Patients
Conditions: Critical Illness;   Mechanical Ventilation Complication
Interventions: Procedure: Enteral Sedation (EN);   Procedure: Control group: Intravenous Sedation (IV)
Outcome Measures: Percent of efficacy, measured by observed RASS = desired RASS ± 1.;   Sedation protocol effectiveness: percentage of "protocol violation days" on the total of ICU days.;   Delirium and coma free days (respectively negative CAM-ICU and RASS > - 3 in all daily observations until 28° ICU day) (11);   Ventilation free days (12);   Nursing evaluation of sedation adequacy (communication skills, cooperation, environment tolerance) (13);   Overall ICU and hospital mortality, absolute mortality after 1 year from ICU discharge.;   Sedative drugs costs.;   Indirect inefficacy markers
6 Unknown  Neurocognitive Functioning Following The PROMETA® Treatment Protocol In Subjects With Alcohol Dependence
Condition: Alcohol Dependence
Intervention: Drug: Prometa Treatment Program
Outcome Measures: The primary outcome measure is neurocognitive functioning as assessed by a battery of standardized neurocognitive tests that assess, executive functioning, verbal memory, general intelligence, and attention.;   Secondary outcome measures include, alcohol craving, subject retention, percent of abstinent days, percent of heavy drinking days, time to first heavy drinking day, and blood chemistries including liver enzymes, reports of side effects.
7 Recruiting Estimate the Efficiency of the Association of an Injection of Ketamine and the Venlafaxine in the Severe Major Depressive Disorder for Six Weeks
Condition: Major Depressive Disorder
Interventions: Drug: ketamine venlafaxine;   Drug: Venlafaxine
Outcome Measure: Depressive state